vs
Side-by-side financial comparison of Laird Superfood, Inc. (LSF) and TRANSCONTINENTAL REALTY INVESTORS INC (TCI). Click either name above to swap in a different company.
Laird Superfood, Inc. is the larger business by last-quarter revenue ($13.3M vs $12.1M, roughly 1.1× TRANSCONTINENTAL REALTY INVESTORS INC). TRANSCONTINENTAL REALTY INVESTORS INC runs the higher net margin — 68.8% vs -13.2%, a 81.9% gap on every dollar of revenue. On growth, Laird Superfood, Inc. posted the faster year-over-year revenue change (15.0% vs 2.3%). Over the past eight quarters, Laird Superfood, Inc.'s revenue compounded faster (16.1% CAGR vs 0.7%).
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
Transcontinental Realty Investors Inc. (TCI) is a U.S.-based real estate investment firm that owns, operates and develops a diversified portfolio of residential, commercial and mixed-use properties across core U.S. regional markets. It pursues long-term value growth via strategic property acquisitions, efficient asset management and tailored leasing solutions for individual and business tenants.
LSF vs TCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $13.3M | $12.1M |
| Net Profit | $-1.8M | $8.3M |
| Gross Margin | 34.1% | — |
| Operating Margin | -13.5% | -28.9% |
| Net Margin | -13.2% | 68.8% |
| Revenue YoY | 15.0% | 2.3% |
| Net Profit YoY | -341.4% | 7577.8% |
| EPS (diluted) | — | $0.97 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $12.1M | ||
| Q3 25 | $12.9M | $12.8M | ||
| Q2 25 | $12.0M | $12.2M | ||
| Q1 25 | $11.7M | $12.0M | ||
| Q4 24 | $11.6M | $11.8M | ||
| Q3 24 | $11.8M | $11.6M | ||
| Q2 24 | $10.0M | $11.8M | ||
| Q1 24 | $9.9M | $11.9M |
| Q4 25 | $-1.8M | $8.3M | ||
| Q3 25 | $-975.1K | $724.0K | ||
| Q2 25 | $-362.2K | $169.0K | ||
| Q1 25 | $-156.2K | $4.6M | ||
| Q4 24 | $-398.4K | $108.0K | ||
| Q3 24 | $-166.1K | $1.7M | ||
| Q2 24 | $-239.1K | $1.5M | ||
| Q1 24 | $-1.0M | $2.5M |
| Q4 25 | 34.1% | — | ||
| Q3 25 | 36.5% | — | ||
| Q2 25 | 39.9% | — | ||
| Q1 25 | 41.9% | — | ||
| Q4 24 | 38.6% | — | ||
| Q3 24 | 43.0% | — | ||
| Q2 24 | 41.8% | — | ||
| Q1 24 | 40.0% | — |
| Q4 25 | -13.5% | -28.9% | ||
| Q3 25 | -7.7% | -10.9% | ||
| Q2 25 | -3.3% | -6.8% | ||
| Q1 25 | -1.9% | -5.3% | ||
| Q4 24 | -4.1% | -14.3% | ||
| Q3 24 | -2.3% | -14.4% | ||
| Q2 24 | -3.4% | -9.2% | ||
| Q1 24 | -11.0% | -11.2% |
| Q4 25 | -13.2% | 68.8% | ||
| Q3 25 | -7.6% | 5.6% | ||
| Q2 25 | -3.0% | 1.4% | ||
| Q1 25 | -1.3% | 38.5% | ||
| Q4 24 | -3.4% | 0.9% | ||
| Q3 24 | -1.4% | 14.7% | ||
| Q2 24 | -2.4% | 12.7% | ||
| Q1 24 | -10.3% | 21.4% |
| Q4 25 | — | $0.97 | ||
| Q3 25 | — | $0.08 | ||
| Q2 25 | — | $0.02 | ||
| Q1 25 | — | $0.53 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | — | $0.20 | ||
| Q2 24 | — | $0.17 | ||
| Q1 24 | — | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | $89.0M |
| Total DebtLower is stronger | — | $210.8M |
| Stockholders' EquityBook value | $11.5M | $846.7M |
| Total Assets | $19.2M | $1.1B |
| Debt / EquityLower = less leverage | — | 0.25× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $89.0M | ||
| Q3 25 | $5.1M | $82.7M | ||
| Q2 25 | $3.9M | $73.5M | ||
| Q1 25 | $7.0M | $88.6M | ||
| Q4 24 | $8.3M | $99.7M | ||
| Q3 24 | $7.9M | $131.6M | ||
| Q2 24 | $7.6M | $127.5M | ||
| Q1 24 | $7.1M | $130.8M |
| Q4 25 | — | $210.8M | ||
| Q3 25 | — | $223.5M | ||
| Q2 25 | — | $212.4M | ||
| Q1 25 | — | $198.2M | ||
| Q4 24 | — | $181.9M | ||
| Q3 24 | — | $180.3M | ||
| Q2 24 | — | $177.4M | ||
| Q1 24 | — | $178.3M |
| Q4 25 | $11.5M | $846.7M | ||
| Q3 25 | $12.8M | $838.4M | ||
| Q2 25 | $13.4M | $837.7M | ||
| Q1 25 | $13.3M | $837.3M | ||
| Q4 24 | $13.2M | $832.3M | ||
| Q3 24 | $13.1M | $832.2M | ||
| Q2 24 | $12.6M | $830.4M | ||
| Q1 24 | $12.7M | $828.9M |
| Q4 25 | $19.2M | $1.1B | ||
| Q3 25 | $18.9M | $1.1B | ||
| Q2 25 | $20.4M | $1.1B | ||
| Q1 25 | $21.5M | $1.1B | ||
| Q4 24 | $19.3M | $1.1B | ||
| Q3 24 | $18.8M | $1.1B | ||
| Q2 24 | $18.0M | $1.0B | ||
| Q1 24 | $17.6M | $1.0B |
| Q4 25 | — | 0.25× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $68.4K | $-2.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | -0.35× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.4K | $-2.9M | ||
| Q3 25 | $1.2M | $8.2M | ||
| Q2 25 | $-2.8M | $-2.9M | ||
| Q1 25 | $-1.3M | $-7.4M | ||
| Q4 24 | $339.2K | $1.3M | ||
| Q3 24 | $305.8K | $13.7M | ||
| Q2 24 | $642.7K | $-511.0K | ||
| Q1 24 | $-422.3K | $3.9M |
| Q4 25 | — | -0.35× | ||
| Q3 25 | — | 11.28× | ||
| Q2 25 | — | -17.24× | ||
| Q1 25 | — | -1.61× | ||
| Q4 24 | — | 12.13× | ||
| Q3 24 | — | 8.03× | ||
| Q2 24 | — | -0.34× | ||
| Q1 24 | — | 1.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
TCI
Segment breakdown not available.